Your guide to IBD novel treatments and assessment tools
UEG Week 2018 saw a host of insights and symposia surrounding the assessment and treatment of Irritable Bowl Disease (IBD). Our expert faculty explored these recent advances and looked at the potential impact that biosimilars could have. Below is a round up of some of the key findings for you to explore for free at your own convenience.
Symposium highlights
New assessment tools in IBD may change your clinical practice. In this educational symposium 'Current IBD Management Strategies: Role of disease assessment' our expert faculty discuss assessment tools including the IBD index, and more. Watch the symposium here
Bitesize expert opinion
Hear from Dr Krisztina Gecse, distilling best practice use of currently available assessment tools, the role that biomarkers can play, and the potential of biosimilars to alter the current treatment paradigm. Watch the interviews
The view from UEG Week 2018
Review the report and analysis from a packed UEGW Vienna as we present daily reviews compiled by our team of scientific writers. Read the reports here
Visit the inflamatory bowel disease assessment tool learning zone
100 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.